Results for tag: "Quadracel"

The Quadracel market is a segment of the Vaccines industry that focuses on combination vaccines. Quadracel vaccines are designed to protect against four different diseases, such as diphtheria, tetanus, pertussis, and poliomyelitis. These vaccines are typically administered to children aged four to six years old, and are often given in a single injection. Quadracel vaccines are designed to provide long-term protection against the four diseases, and are considered to be a cost-effective way to protect against multiple diseases. The Quadracel market is a growing segment of the Vaccines industry, with many companies offering Quadracel vaccines. Some of the companies in the market include Sanofi Pasteur, GlaxoSmithKline, Merck, Pfizer, and Novartis. Show Less Read more